Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 3Unknown 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Surgical Wound Infection 1Rectal Neoplasms 1Pancreatic Neoplasms 1Pancreatic Fistula 1Duodenal Neoplasms 1Colorectal Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Oxaliplatin 95Fluorouracil 84Capecitabine 75Gemcitabine 72Leucovorin 68Nivolumab 67Bevacizumab 63pembrolizumab 61Magnetic Resonance Spectroscopy 52Specimen Handling 50Irinotecan 50durvalumab 46Radiotherapy 42atezolizumab 40Cisplatin 39Paclitaxel 37Biopsy 37130-nm albumin-bound paclitaxel 34Cetuximab 30Carboplatin 27Albumin-Bound Paclitaxel 26Taxes 24Drug Therapy 20dehydroftorafur 19Radiation 19Ipilimumab 19tislelizumab 18Standard of Care 17Docetaxel 17trifluridine tipiracil drug combination 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Anti-Bacterial Agents × Gastrointestinal × Clear all
NCT03631173 2026-04-28

MINIMUM

Oslo University Hospital

Phase NA Active not recruiting
201 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Duodenal Neoplasms, Pancreatic Fistula, Pancreatic Neoplasms

NCT04281667 2022-11-17

MOBILE2

Helsinki University Central Hospital

Phase 4 Active not recruiting
604 enrolled
Gastrointestinal

Rectal Neoplasms, Surgical Wound Infection, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡